Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab

Defining how epidermal growth factor receptor (EGFR)-targeting therapies influence the immune response is essential to increase their clinical efficacy. A growing emphasis is being placed on immune regulator genes that govern tumor – T cell interactions. Previous studies showed an increase in HLA cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrido, Greta, Rabasa, Ailem, Garrido, Cristina, Chao, Lisset, Garrido, Federico, García-Lora, Ángel M., Sánchez-Ramírez, Belinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635422/
https://www.ncbi.nlm.nih.gov/pubmed/29056908
http://dx.doi.org/10.3389/fphar.2017.00595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635422/
https://www.ncbi.nlm.nih.gov/pubmed/29056908
http://dx.doi.org/10.3389/fphar.2017.00595

Ejemplares similares